Titration of Marek's Disease Cell-Associated Vaccine Virus (CVI 988) of Reconstituted Vaccine and Vaccine Ampoules from Dutch Hatcheries

Abstract SUMMARY. Thirty-one outbreaks of Marek's disease (MD) were reported in the Netherlands and retrospectively analyzed. The outbreaks occurred mostly in vaccinated commercial layer and a few breeder flocks of several breeds; however, the cause of the outbreaks could not be established. Therefore, in a prospective study, the occurrence of true vaccine failures was assessed on five hatcheries. The plaque-forming units (PFU) of MD vaccine per chicken dose were determined through in vitro assays on vaccine ampoules (2 to 5 per hatchery) and samples of reconstituted vaccine (approximately 22 per hatchery). All forty reconstituted vaccine samples of hatcheries 1 and 4 showed PFU doses <103. In hatchery 4, 14 samples showed extreme low PFU (≤10 PFU). In hatcheries 2, 3, and 5, the numbers of MD vaccine suspensions with a titer ≥103 PFU, which is the standard required, were 1 (5%), 17 (77%), and 3 (14%), respectively. Some vaccine ampoules showed <103 PFU per chicken dose. This study shows the usefulness to assess the PFU per chicken dose of reconstituted MD vaccine and vaccine ampoules to unravel true vaccine failures, which could result in disease outbreaks in the field.

[1]  W. Landman,et al.  Investigations of Enterococcus faecalis-induced bacteraemia in brown layer pullets through different inoculation routes in relation to the production of arthritis , 2003, Avian pathology : journal of the W.V.P.A.

[2]  W. Landman,et al.  Molecular epidemiology of unilateral amyloid arthropathy in broiler breeders associated with Enterococcus faecalis , 2002, Avian pathology : journal of the W.V.P.A.

[3]  R. Witter Protective efficacy of Marek's disease vaccines. , 2001, Current topics in microbiology and immunology.

[4]  P. Doornenbal,et al.  Contamination of Marek's disease vaccine suspensions with Enterococcus faecalis and its possible role in amyloid arthropathy , 2000, Avian pathology : journal of the W.V.P.A.

[5]  P. Doornenbal,et al.  Arthropathic and amyloidogenic Enterococcus faecalis infections in brown layers: A study on infection routes. , 1999, Avian pathology : journal of the W.V.P.A.

[6]  W. Landman,et al.  Arthropatic and amyloidogenic E. faecalis infections in brown layers: a study on infection routes , 1999 .

[7]  T. Nunoya,et al.  Depression of vaccinal immunity to Marek's disease by infection with chicken anaemia agent. , 1988, Avian pathology : journal of the W.V.P.A.

[8]  H. Landgraf,et al.  [Prevention of Marek's disease by various vaccination viruses following test infection at various ages, study of PD50]. , 1986, DTW. Deutsche tierarztliche Wochenschrift.

[9]  G. F. de Boer,et al.  Comparison of intramuscular and subcutaneous administration of Marek's disease vaccine. , 1986, Avian pathology : journal of the W.V.P.A.

[10]  R. Witter Principles of Vaccination , 1985 .

[11]  J. M. Sharma Effect of infectious bursal disease virus on protection against Marek's disease by turkey herpesvirus vaccine. , 1984, Avian diseases.

[12]  J. M. Sharma,et al.  Resistance to Marek's disease at hatching in chickens vaccinated as embryos with the turkey herpesvirus. , 1982, Avian diseases.

[13]  L. Barendregt,et al.  Comparative 50% protective dose assays (PD50) of Marek's disease virus strain CVI988. , 1981, Journal of biological standardization.

[14]  L. Lee,et al.  Depression of vaccinal immunity to Marek's disease by infection with reticuloendotheliosis virus , 1979, Infection and immunity.

[15]  R. Witter,et al.  Differential effect of maternal antibodies on efficacy of cellular and cell-free Marek's disease vaccines. , 1979, Avian pathology : journal of the W.V.P.A.

[16]  D. Mitchell,et al.  Loss of cell-associated Marek's disease vaccine titer during thawing, reconstitution, and use. , 1979, Avian diseases.

[17]  R. K. Page,et al.  Effectiveness of cell-free or cell-associated turkey herpesvirus vaccine against Marek's disease in chickens as influenced by maternal antibody, vaccine dose, and time of exposure to Marek's disease virus. , 1978, Avian diseases.

[18]  Ball Rf,et al.  Revaccination of chicks for Marek's disease at twenty-one days old. , 1977 .

[19]  R. F. Ball,et al.  Revaccination of chicks for Marek's disease at twenty-one days old. , 1977, Avian diseases.

[20]  O. Basarab,et al.  Comparisons of cell-free and cell-associated Marek's disease vaccines in maternally immune chicks , 1976, Veterinary Record.

[21]  B. Calnek Influence of age at exposure on the pathogenesis of Marek's disease. , 1973, Journal of the National Cancer Institute.

[22]  N. Yuasa,et al.  Dose effect of herpesvirus of turkeys on protection of chickens from Marek's disease. , 1973, National Institute of Animal Health quarterly.

[23]  R. Witter,et al.  An age-related resistance of chickens to Marek's disease: some preliminary observations. , 1973, Avian pathology : journal of the W.V.P.A.

[24]  W. Okazaki,et al.  The minimum protective dose of the herpesvirus turkeys vaccine against Marek's disease , 1972, Veterinary Record.

[25]  K. Schat,et al.  Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials. , 1972, Avian diseases.

[26]  B. Calnek,et al.  Vaccination with lyophilized turkey herpesvirus (HVT): minimum infective and protective doses. , 1972, Avian diseases.

[27]  K. Schat,et al.  Control of Marek's disease in the Netherlands. II. Field trials on vaccination with an avirulent strain (CVI 988) of Marek's disease virus. , 1972, Avian diseases.

[28]  R. Witter,et al.  Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. , 1970, American journal of veterinary research.

[29]  P. Biggs,et al.  Agent of Marek's Disease in Tissue Culture , 1967, Nature.